Gastrointestinal Drugs Market Size And Share

  • Report Code : TIPRE00014758
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 211
Buy Now

Gastrointestinal Drugs Market Share, Size, and Outlook by 2027

Buy Now

Gastrointestinal Drugs Market Report Gastrointestinal Drugs Market Scope and Analysis Gastrointestinal Drugs Market Size and Share

Gastrointestinal Drugs Market: Strategic Insights

Gastrointestinal Drugs Market

  • CAGR (2023 - 2031)
    7.5%
  • Market Size 2023
    US$ 59,713.68 Million
  • Market Size 2031
    US$ 106,304.81 Million

Market Dynamics

GROWTH DRIVERS
  • Increasing prevelance of gastrointestinal diosrders creates demnad for gastrointestinal drugs
FUTURE TRENDS
  • Increasing research investment for novel drug development and artificial intelligence-based techniques are the key trand in coming years
OPPORTUNITIES
  • Strategic Initiatives by Companies are likely to create ample opportunities in the coming years

Key Players

  • Sanofi SA
  • GSK Plc
  • Johnson Johnson
  • Bausch Health Companies Inc
  • AstraZeneca Pl
  • Takeda Pharmaceutical Co Ltd
  • AbbVie Inc
  • Bayer AG
  • Pfizer Inc
  • Celltrion Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Drug Class
  • Biologics
  • Antidiarrheal and Laxatives
  • Acid Neutralizers
  • Anti-inflammatory Drugs
  • Antiemetic and Antinauseants
Application
  • Irritable Bowel Syndrome
  • Inflammatory Ulcerative Colitis
  • Crohns Disease
  • Gastroenteritis
  • Celiac Disease
Route Of Administration
  • Oral and Parenteral
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies